Jetema selected for 8.12 billion won R&D project to develop human-collagen medical devices
Translated from Korean and summarized by DistantNews. Read the original for the full story.
At a glance
- South Korean medical-device company Jetema was selected for a government-led biotechnology and healthcare research project worth 8.12 billion won.
- The project will develop a manufacturing process for medical-grade human collagen and Class IV medical devices using AI sequence design and process modeling.
- The research is scheduled to run from July 2026 through December 2030.
Jetema has been selected for an 8.12 billion won ($5.9 million) research and development project focused on human-collagen medical devices, the company said on the 8th.
The project, led by South Koreaโs Ministry of Trade, Industry and Energy, aims to develop a manufacturing process for medical-grade human collagen based on artificial-intelligence sequence design and process modeling.
It also includes the development of Class IV medical devices. The research period is scheduled to run from July 2026 to December 2030, covering about five years.
Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.